ASH 2022 Conference Coverage
ASH 2022 Low-Molecular-Weight Heparin vs. Standard Pregnancy Care for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial
By
ASH 2022 Conference Coverage
FEATURING
Saskia Middeldorp
By
ASH 2022 Conference Coverage
FEATURING
Saskia Middeldorp
Login to view comments.
Click here to Login